Observational studyJournal of general internal medicine2025
Racial Inequality in Receipt of Medications for Opioid Use Disorder in Nationwide Outpatient Settings-A Cross-sectional Study.
Observational study in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe surge in drug overdose fatalities in the USA, particularly from synthetic opioids, highlights the need for effective interventions. Medication for opioid use disorder (MOUD) shows promise in treatment, but disparities in access persist.
objectiveThis study was designed to investigate disparities in MOUD receipt in the outpatient settings for patients diagnosed with opioid use disorder (OUD).
designObservational cohort study.
participantsThe nationwide electronic medical record (EMR) from the IQVIA Ambulatory EMR-US database was utilized, comprising 32,929 patients diagnosed with OUD between January 2014 and September 2022. The analysis focused on Black and White populations, the majority of whom have commercial insurance. MAIN MEASURES: Access to FDA-approved medications for OUD treatment within 180 days after index OUD diagnosis across the USA were measured by medication receipt rate, average days of medication supply, and retention rate. KEY
resultNotable racial disparities were identified in MOUD receipt, with Black population having significantly lower rates than White. State-level disparities were also evident, with 25 out of 41 states showing lower MOUD receipt rates among Black than in White population. Quarterly trends in receipt rates showed lower rates among Black population in most years. Additionally, the average days of supply for MOUD prescriptions were lower for Black population across most states.
conclusionsSignificant racial and state-level disparities exist in MOUD receipt among patients in outpatient settings. The study underscores the need for targeted interventions to address these inequities in MOUD access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.